Cell Therapy Research Solutions

Cell Therapy Enablement

New cell-based therapies are ready to transform medicine by providing highly personal and effective treatments. Cancer and spinal cord injury therapies are just two areas where clinical trials are showing promising results.

As a leader in cell analysis and isolation, BD is uniquely positioned to help researchers and developers address the emerging needs in this rapidly advancing field.

Cell therapy development and production is complex and demands the highest standards in safety and efficacy. BD’s wide portfolio of current and soon to be released cell analyzers brings a history of superior quality and the ability to reveal the identity and function of billions of cells, one at a time.

A key challenge in cell therapy development today is the purity of cell preparations. Diluted or impure cell populations can be less efficacious, and unwanted cells may present safety concerns. Combining droplet-based flow cytometry with BD's proven FACS™ technology provides the highest grade of purity achievable today, enabling:

  • ≥98% purity for many applications
  • Multiparameter isolation of complex phenotypes

Our custom multicolor cell sorting reagents can be tested for sterility, toxicity, and lack of microbial or viral contamination and manufactured in cGMP compliance. Lyophilization for longer shelf life is available upon request.

BD holds a license to US patent number 7,947,464 which describes methods for identifying regulatory T cells and includes the use of CD127, CD25 and CD4. Please contact  [email protected] for sub-licensing information.

BD Influx™ cell sorter

  • Highly customizable
  • Up to 10 lasers and 24 parameters
  • Multiple nozzle sizes
  • Class II Type A2 BSC available
  • Aseptic replaceable fluidics

New BD Cytopeia™ fluidic kit

  • Improved kit design (SAL of 10-6)
  • New sterile sheath bag with DPBS
  • Optional sterile in-line sheath filter
  • Sheath tank
  • Available for BD Influx and BD FACSJazz

Custom cGMP reagents for cell isolation

Specificity Clone Format
CD4 (L200) PerCP
CD25 (2A3) APC
CD127 (40131) PE

Please contact  [email protected]

In-depth characterization of cell populations and discovery of biomarkers remain central to the successful development of safe and efficacious cell therapies. Flow cytometry represents a unique technology platform in this context, providing high-content information at the single cell level based on surface markers and intracellular characteristics.

BD is recognized as a leader in this field with best-in-class fluorescent dyes and instrumentation and a broad antibody portfolio. BD software, setup and control reagents, in combination with its high-quality reagents and instrumentation, enables the highest level of standardization in cell therapy.



High performance integrated solution for accurate, reliable  
and repeatable results across users, instruments, and sites.


A powerful benchtop system designed to ensure accuracy,  
repeatability, and ease-of-use.


Cell analyzer with proven reliability and high-quality results  
supporting up to 10 parameters. 

Cell Characterization Antibodies for Cell Therapy Development

  Regulatory Status Format Product Highlights
Single vials RUO or RUO GMP Liquid
  • >6,000 directly conjugated RUO antibodies (ISO certified)
  • >300 directly conjugated RUO GMP antibodies
  • Innovative dye technology developed by Sirigen provides brighter dye options for better cell separation and easier multicolor analysis
Custom antibody cocktails RUO or RUO GMP
  • Liquid or lyophilized
  • In vials or 96-well plates
BD™ Lyoplate format flexibility permits user-defined experiment layouts, including the exact content of each well within the plate

BD has been a pioneer and a trusted partner of leading biopharmaceutical companies around the world. As a result, our products are used in the manufacture of more than 110 animal and human health biopharmaceuticals on the market today. Leveraging our experience in developing cell culture media, supplements and feeds, we are now working on cost-effective cell therapy expansion media to help you achieve optimal and consistence performance.

MSC Media

Our proprietary Mesenchymal Stem Cell (MSC) serum-free expansion medium optimizes performance to deliver more cell doublings per passage without refeeding, while maintaining normal MSC phenotype and function.  Contact us for more information.

Media Services

Our experience, combined with our proven methodology and extensive analytical capabilities, allows us to provide customers with customized cell therapy expansion medium solution.

Media Manufacturing

As part of BD’s global network of manufacturing centers, BD is focused on the development and manufacturing of media and supplements.

  • Small-scale, rapid medium production
  • GMP production
  • Animal-free, antibiotic-free facility
  • Compliant with 21 CFR Parts 210 and 211 regulations for the manufacture of finished pharmaceuticals
  • ISO 9001 certified

Class 1 Laser Product.

Unless otherwise noted, For Research Use Only. Not for use in diagnostic or therapeutic procedures.

The BD FACSLyric™ flow cytometer is for In Vitro Diagnostic Use with BD FACSuite™ Clinical software for up to 6 colors.

The BD FACSLyric™ flow cytometer is for Research Use Only with BD FACSuite™ software for up to 12 colors.

The 12-color BD FACSLyric™ flow cytometer is for Research Use Only.

The BD FACSVia™ flow cytometer and BD FACSCanto™ flow cytometer is for In Vitro Diagnostic Use.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience. 

下载腾讯棋牌 看图能预测股票涨跌吗 甘肃快三 一定牛 现金在线娱乐 浙江11选5中奖条件 北京快乐8360开奖 日本股票指数叫什么 广东快乐十分安卓 11选5在线山东视频 上海快三官网下载 辽宁11选5手机版规则